BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9599702)

  • 1. Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.
    Parchment RE
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):541-57. PubMed ID: 9599702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematotoxicology: scientific basis and regulatory aspects.
    Gribaldo L
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():111-3. PubMed ID: 12513660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests.
    Parchment RE; Gordon M; Grieshaber CK; Sessa C; Volpe D; Ghielmini M
    Ann Oncol; 1998 Apr; 9(4):357-64. PubMed ID: 9636825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.
    Pessina A; Albella B; Bayo M; Bueren J; Brantom P; Casati S; Croera C; Gagliardi G; Foti P; Parchment R; Parent-Massin D; Schoeters G; Sibiril Y; Van Den Heuvel R; Gribaldo L
    Toxicol Sci; 2003 Oct; 75(2):355-67. PubMed ID: 12883091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative methods in toxicology: CFU assays application, limitation and future prospective.
    Yadav NK; Shukla P; Omer A; Singh P; Singh RK
    Drug Chem Toxicol; 2016; 39(1):1-12. PubMed ID: 25678196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproduction and development.
    Spielmann H
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):571-6. PubMed ID: 9599704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro tests for haematotoxicity: prediction of drug-induced myelosuppression by the CFU-GM assay.
    Pessina A; Albella B; Bayo M; Bueren J; Brantom P; Casati S; Croera C; Parchment R; Parent-Massin D; Schoeters G; Sibiri Y; Van Den Heuvel R; Gribaldo L
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():75-9. PubMed ID: 12513654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of new technologies to characterization and prediction of adverse effects.
    RouquiƩ D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of QSAR and in vitro toxicology.
    Barratt MD
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):459-65. PubMed ID: 9599692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invertebrates in testing of environmental chemicals: are they alternatives?
    Lagadic L; Caquet T
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):593-611. PubMed ID: 9599707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TestSmart-high production volume chemicals: an approach to implementing alternatives into regulatory toxicology.
    Green S; Goldberg A; Zurlo J
    Toxicol Sci; 2001 Sep; 63(1):6-14. PubMed ID: 11509738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The necessity of biokinetic information in the interpretation of in vitro toxicity data.
    Blaauboer BJ
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():85-91. PubMed ID: 12513656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative models for toxicity testing of xenobiotics.
    Kniewald J; Kmetic I; Gaurina-Srcek V; Kniewald Z
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):195-204. PubMed ID: 15968836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver cell models in in vitro toxicology.
    Guillouzo A
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):511-32. PubMed ID: 9599700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical testing on insects predicts human haematotoxic potentials.
    Berger J
    Lab Anim; 2009 Oct; 43(4):328-32. PubMed ID: 19505933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals.
    Halle W
    Altern Lab Anim; 2003; 31(2):89-198. PubMed ID: 15612878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers, nephrotoxicology and chronic testing in vitro.
    Prieto P
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():101-6. PubMed ID: 12513658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.